Form 8-K - Current report:
SEC Accession No. 0001193125-24-246171
Filing Date
2024-10-29
Accepted
2024-10-29 08:00:55
Documents
31
Period of Report
2024-10-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d821192d8k.htm   iXBRL 8-K 26207
2 EX-99.1 d821192dex991.htm EX-99.1 38585
3 EX-99.2 d821192dex992.htm EX-99.2 20229
7 GRAPHIC g821192ex99_2s10g1.jpg GRAPHIC 100009
8 GRAPHIC g821192ex99_2s11g1.jpg GRAPHIC 100365
9 GRAPHIC g821192ex99_2s12g1.jpg GRAPHIC 73001
10 GRAPHIC g821192ex99_2s13g1.jpg GRAPHIC 97361
11 GRAPHIC g821192ex99_2s14g1.jpg GRAPHIC 97415
12 GRAPHIC g821192ex99_2s15g1.jpg GRAPHIC 85483
13 GRAPHIC g821192ex99_2s16g1.jpg GRAPHIC 116218
14 GRAPHIC g821192ex99_2s1g1.jpg GRAPHIC 88820
15 GRAPHIC g821192ex99_2s2g1.jpg GRAPHIC 241248
16 GRAPHIC g821192ex99_2s3g1.jpg GRAPHIC 169441
17 GRAPHIC g821192ex99_2s4g1.jpg GRAPHIC 58658
18 GRAPHIC g821192ex99_2s5g1.jpg GRAPHIC 122945
19 GRAPHIC g821192ex99_2s6g1.jpg GRAPHIC 90669
20 GRAPHIC g821192ex99_2s7g1.jpg GRAPHIC 84550
21 GRAPHIC g821192ex99_2s8g1.jpg GRAPHIC 100533
22 GRAPHIC g821192ex99_2s9g1.jpg GRAPHIC 106855
  Complete submission text file 0001193125-24-246171.txt   2622276

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coya-20241029.xsd EX-101.SCH 2878
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20241029_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20241029_pre.xml EX-101.PRE 11726
33 EXTRACTED XBRL INSTANCE DOCUMENT d821192d8k_htm.xml XML 3768
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 241402731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)